Evidence map›Paper›PMID 40837939›Full record

ArticleCureus2025

Influence of Age and Sex on the Clinical Profile of Metabolic Syndrome in Diabetic Patients.

Rakesh Uppara Kadiyala, Mohd Asif, Swathi Uppara, Manuj Kumar Sarkar, Saphal Lakshmi Pasupulati, Nangadda Narmada, Sai Sujith Varma Datla, Rajeswari Murugesan, Suresh Vaikkakara, Raviteja Guddeti

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rakesh Uppara KadiyalaGeneral Medicine, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, IND.
Mohd AsifGeneral Medicine, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, IND.
Swathi UpparaPsychiatry, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, IND.
Manuj Kumar SarkarGeneral Medicine, All India Institute of Medical Sciences, Deoghar, Deoghar, IND.
Saphal Lakshmi PasupulatiGeneral Medicine, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, IND.
Nangadda NarmadaEndocrinology, Diabetes and Metabolism, Narayana Health, Bangalore, IND.
Sai Sujith Varma DatlaGeneral Medicine, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, IND.
Rajeswari MurugesanBiostatistics, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, IND.
Suresh VaikkakaraEndocrinology and Diabetes, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, IND.
Raviteja GuddetiCardiovascular Medicine, Creighton University School of Medicine, Omaha, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aim In the 21st century, the rise in metabolic syndrome (MetS) prevalence has made it a global concern due to a higher risk of coronary artery disease and overall mortality, especially in India. Diabetic patients are more susceptible to metabolic syndrome. Therefore, it is crucial to determine the various risk factors associated with diabetes that contribute to the development of MetS. This study aimed to determine the prevalence of MetS and assess the risk factors and individual components of MetS in diabetic patients across both sexes and various age groups. Material and methods This cross-sectional prospective study was conducted in diabetic adults who visited the general medicine outpatient department at All India Institute of Medical Sciences (AIIMS), Mangalagiri. Patients who met the inclusion criteria were enrolled in this study. The collected data were analyzed according to the guidelines of the International Diabetes Federation (IDF) and the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) Joint Scientific Statement (2009) for MetS diagnosis. Results A total of 388 patients with diabetes mellitus were included in this study. The mean age was 52.55±11.82 years, with 20-59 years accounting for 69.6% (n=270) and ≥60 years for 30.4% (n=118). The proportion of males was 52.3% (n=203) of the study population. A high prevalence of MetS was reported (n=316; 81.4%). The prevalence of MetS was slightly higher in the 20-59 years age group (82.6%, n=223) compared to those ≥60 years (78.8%, n=93). A strong correlation between female sex and central obesity (n=168, 90.8%; p<0.001) and lower HDL-C levels (n=146, 78.9%; p<0.001) was present. A significant correlation was found between comorbidities, including hypertension (n=164, 86.3%, p=0.016), dyslipidemia (n=92, 88.5%, p=0.031), and the prevalence of MetS. Multivariable logistic regression analysis revealed that waist circumference (odds ratio {OR}: 1.1; p=0.016), systolic blood pressure (OR: 1.09; p=0.016), fasting blood glucose (OR: 1.02; p=0.044), and triglycerides (OR: 1.02; p=0.025) were independent predictors of MetS. Conclusion This study shows a high prevalence of metabolic syndrome (MetS) among diabetic patients, with females showing higher prevalence of MetS and its components, particularly central obesity and low HDL-C levels. The study also found statistically significant associations between MetS and glycemic parameters such as postprandial blood sugar and hemoglobin A1c (HbA1c). These findings emphasize the need for targeted screening and early intervention, particularly among female and younger diabetic patients. Public health initiatives focusing on lifestyle modifications and glycemic control are essential to mitigate MetS complications. Due to sociocultural diversities, region-specific studies are needed to develop localized guidelines for the effective management and prevention of metabolic syndrome.

Indexed as

cardiovascular diseasediabetes mellitusdyslipidemiahypertensionlifestyle modificationsmetabolic syndromeobesity

Identifiers

PMID40837939
PMCPMC12364449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.